Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting

E. Wardelmann, R. L. Haas, J. V M G Bovée, Ph Terrier, A. Lazar, C. Messiou, C. Lepechoux, W. Hartmann, F. Collin, C. Fisher, G. Mechtersheimer, A. P. Deitos, S. Stacchiotti, R. L. Jones, A. Gronchi, S. Bonvalot

Research output: Contribution to journalArticle

Abstract

At present, there is not a commonly used and generally accepted standardized approach for the pathologic evaluation of pretreated soft tissue sarcomas. Also, it is still unclear whether the cut-off for prognostic relevance is similar in the many different histological subtypes of STS. This manuscript, produced by a European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) endorsed task force, aims to propose standardization of the pathological examination process and the reporting of STS resection specimens after neoadjuvant radio- and/or chemotherapy.

Original languageEnglish
Pages (from-to)84-95
Number of pages12
JournalEuropean Journal of Cancer
Volume53
DOIs
Publication statusPublished - Jan 1 2016

Keywords

  • Chemotherapy
  • Guideline
  • Pathology
  • Radiotherapy
  • Response evaluation
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting'. Together they form a unique fingerprint.

Cite this